Launch of 2022 ATTRACT Call

The FNR is pleased to communicate the launch of the 2022 ATTRACT Call. Pre-proposal deadline is 15 November 2021, 14:00 CET. The ATTRACT programme offers promising junior researchers from abroad up to 2 MEUR of funding over five years to set up their own research group in Luxembourg.

Prior to submitting an application, ATTRACT candidates need to undergo an institutional validation process. Interested candidates are therefore invited to contact potential host institutions in Luxembourg as early as possible to allow sufficient time for institutional validation of their candidature.

Go to ATTRACT programme page

Changes starting with this Call

It is no longer required for ATTRACT applicants to upload a traditional CV. Instead, they are required to present their profile, their achievements, their motivation, etc. in a narrative style in the frame of the project description; they are further required to have an up-to-date ORCID profile.

Two dedicated budget lines have been added, for “Training and HR Development” and “Open Science and Research Data Management”.

An outline of the candidate’s career development plan, indicating the planned evaluation(s) for tenure/promotion, the evaluation criteria and the main targets and objectives to be achieved by the candidates, must be joined to the full proposal.

Related news & highlights

New video resource for funders: ‘Balanced, broad, responsible: A practical guide for research evaluators’

FNR-funded projects during COVID-19: FAQs for grantholders & applicants

Chercheurs à l’école: researchers, meet the next generation! FINAL SESSIONS

  • All
  • Humanities & Social Sciences
  • Life Sciences, Biology & Medicine
  • Spotlight on Young Researchers
  • Sustainable resource mgmt
  • Women in science

Spotlight on Young Researchers: Increasing the diversity of plant species used for vegetable oil

Spotlight on Young Researchers: Overcoming antiquated ideas about history

Spotlight on Young Researchers: Glioblastoma and the challenge of getting cancer drugs to reach the brain

This site uses cookies. By continuing to use this site, you agree to the use of cookies for analytics purposes. Find out more in our Privacy Statement